HomeFingolimod Lauryl SulfateFingolimod Lauryl Sulfate + Nonselective Beta Adrenergic Antagonists

Does Fingolimod Lauryl Sulfate Interact with Nonselective Beta Adrenergic Antagonists?

Fingolimod Lauryl Sulfate and Nonselective Beta Adrenergic Antagonists have a major drug interaction according to U.S. FDA drug labeling data. Risk of severe bradycardia or heart block with concomitant use during TASCENSO ODT initiation. Limited experience in concurrent therapy. The mechanism involves tascenso odt causes additional decrease in heart rate. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Fingolimod Lauryl Sulfate and Nonselective Beta Adrenergic Antagonists occurs because tascenso odt causes additional decrease in heart rate. Clinically, this means risk of severe bradycardia or heart block with concomitant use during tascenso odt initiation. limited experience in concurrent therapy. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Fingolimod Lauryl Sulfate and your doctor is considering prescribing Nonselective Beta Adrenergic Antagonists (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Fingolimod Lauryl Sulfate(Tascenso Odt)+💊 Nonselective Beta Adrenergic Antagonists

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Source
NLP:fingolimod lauryl sulfate

What this means in plain English

Risk of severe bradycardia or heart block with concomitant use during TASCENSO ODT initiation. Limited experience in concurrent therapy.

What the FDA label says

"TASCENSO ODT causes additional decrease in heart rate"

📖 Source: NLP:fingolimod lauryl sulfate

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Fingolimod Lauryl Sulfate and Nonselective Beta Adrenergic Antagonists against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.